Pablo J. Cagnoni
2019
In 2019, Pablo J. Cagnoni earned a total compensation of $1.7M as Chief Executive Officer at Rubius Therapeutics.
Compensation breakdown
| Bonus | $211,750 |
|---|---|
| Option Awards | $935,250 |
| Salary | $547,500 |
| Other | $26,630 |
| Total | $1,721,130 |
Cagnoni received $935.3K in option awards, accounting for 54% of the total pay in 2019.
Cagnoni also received $211.8K in bonus, $547.5K in salary and $26.6K in other compensation.
Rankings
In 2019, Pablo J. Cagnoni's compensation ranked 6,652nd out of 13,971 executives tracked by ExecPay. In other words, Cagnoni earned more than 52.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,652 out of 13,971 | 52nd |
Division Manufacturing | 2,529 out of 5,698 | 56th |
Major group Chemicals And Allied Products | 917 out of 2,197 | 58th |
Industry group Drugs | 775 out of 1,883 | 59th |
Industry Biological Products, Except Diagnostic Substances | 185 out of 389 | 52nd |
Source: SEC filing on March 30, 2021.
Cagnoni's colleagues
We found one more compensation record of an executive who worked with Pablo J. Cagnoni at Rubius Therapeutics in 2019.
2019
Maiken Keson-Brookes
Rubius Therapeutics